Illustrative image – not actual.Sharon Bio-Medicine has commissioned expansion of its three manufacturing facilities.
The company has invested nearly Rs 125 crore in these projects. Sharon Bio-Medicine has doubled the capacity of its Dehradun Formulation plant, in Uttarakhand, at an investment of around Rs 85 crore.
Similarly, the company has commissioned its two other plants at Taloja near Navi Mumbai, Maharashtra. It has added between 30 per cent and 50 per cent capacity at these plants.
Commercial production at the company's two expanded plants at Taloja, near Navi Mumbai, have already been started, while the facility in Dehra Dun will start production from June 2014.
